Cost of Revenue of NRX Pharmaceuticals, Inc. from 30 Sep 2024 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
NRX Pharmaceuticals, Inc. quarterly Cost of Revenue in USD history and change rate from 30 Sep 2024 to 30 Sep 2025.
  • NRX Pharmaceuticals, Inc. Cost of Revenue for the quarter ending 30 Sep 2025 was $97,000.
Source SEC data
View on sec.gov
Cost of Revenue, Quarterly (USD)

NRX Pharmaceuticals, Inc. Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $97,000 +$97,000 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2024 Q3
Q3 2024 $0 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2024 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.